Clinical Clostridium difficile: clonality and pathogenicity locus diversity.

Clostridium difficile infection (CDI) is an important cause of mortality and morbidity in healthcare settings. The major virulence determinants are large clostridial toxins, toxin A (tcdA) and toxin B (tcdB), encoded within the pathogenicity locus (PaLoc). Isolates vary in pathogenicity from hypervi...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Kate E Dingle, David Griffiths, Xavier Didelot, Jessica Evans, Alison Vaughan, Melina Kachrimanidou, Nicole Stoesser, Keith A Jolley, Tanya Golubchik, Rosalind M Harding, Tim E Peto, Warren Fawley, A Sarah Walker, Mark Wilcox, Derrick W Crook
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2011
Materias:
R
Q
Acceso en línea:https://doaj.org/article/92cb5d60d0a1471a9ee089980e7b83ff
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:92cb5d60d0a1471a9ee089980e7b83ff
record_format dspace
spelling oai:doaj.org-article:92cb5d60d0a1471a9ee089980e7b83ff2021-11-18T06:53:42ZClinical Clostridium difficile: clonality and pathogenicity locus diversity.1932-620310.1371/journal.pone.0019993https://doaj.org/article/92cb5d60d0a1471a9ee089980e7b83ff2011-01-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/21625511/?tool=EBIhttps://doaj.org/toc/1932-6203Clostridium difficile infection (CDI) is an important cause of mortality and morbidity in healthcare settings. The major virulence determinants are large clostridial toxins, toxin A (tcdA) and toxin B (tcdB), encoded within the pathogenicity locus (PaLoc). Isolates vary in pathogenicity from hypervirulent PCR-ribotypes 027 and 078 with high mortality, to benign non-toxigenic strains carried asymptomatically. The relative pathogenicity of most toxigenic genotypes is still unclear, but may be influenced by PaLoc genetic variant. This is the largest study of C. difficile molecular epidemiology performed to date, in which a representative collection of recent isolates (n = 1290) from patients with CDI in Oxfordshire, UK, was genotyped by multilocus sequence typing. The population structure was described using NeighborNet and ClonalFrame. Sequence variation within toxin B (tcdB) and its negative regulator (tcdC), was mapped onto the population structure. The 69 Sequence Types (ST) showed evidence for homologous recombination with an effect on genetic diversification four times lower than mutation. Five previously recognised genetic groups or clades persisted, designated 1 to 5, each having a strikingly congruent association with tcdB and tcdC variants. Hypervirulent ST-11 (078) was the only member of clade 5, which was divergent from the other four clades within the MLST loci. However, it was closely related to the other clades within the tcdB and tcdC loci. ST-11 (078) may represent a divergent formerly non-toxigenic strain that acquired the PaLoc (at least) by genetic recombination. This study focused on human clinical isolates collected from a single geographic location, to achieve a uniquely high density of sampling. It sets a baseline of MLST data for future comparative studies investigating genotype virulence potential (using clinical severity data for these isolates), possible reservoirs of human CDI, and the evolutionary origins of hypervirulent strains.Kate E DingleDavid GriffithsXavier DidelotJessica EvansAlison VaughanMelina KachrimanidouNicole StoesserKeith A JolleyTanya GolubchikRosalind M HardingTim E PetoWarren FawleyA Sarah WalkerMark WilcoxDerrick W CrookPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 6, Iss 5, p e19993 (2011)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Kate E Dingle
David Griffiths
Xavier Didelot
Jessica Evans
Alison Vaughan
Melina Kachrimanidou
Nicole Stoesser
Keith A Jolley
Tanya Golubchik
Rosalind M Harding
Tim E Peto
Warren Fawley
A Sarah Walker
Mark Wilcox
Derrick W Crook
Clinical Clostridium difficile: clonality and pathogenicity locus diversity.
description Clostridium difficile infection (CDI) is an important cause of mortality and morbidity in healthcare settings. The major virulence determinants are large clostridial toxins, toxin A (tcdA) and toxin B (tcdB), encoded within the pathogenicity locus (PaLoc). Isolates vary in pathogenicity from hypervirulent PCR-ribotypes 027 and 078 with high mortality, to benign non-toxigenic strains carried asymptomatically. The relative pathogenicity of most toxigenic genotypes is still unclear, but may be influenced by PaLoc genetic variant. This is the largest study of C. difficile molecular epidemiology performed to date, in which a representative collection of recent isolates (n = 1290) from patients with CDI in Oxfordshire, UK, was genotyped by multilocus sequence typing. The population structure was described using NeighborNet and ClonalFrame. Sequence variation within toxin B (tcdB) and its negative regulator (tcdC), was mapped onto the population structure. The 69 Sequence Types (ST) showed evidence for homologous recombination with an effect on genetic diversification four times lower than mutation. Five previously recognised genetic groups or clades persisted, designated 1 to 5, each having a strikingly congruent association with tcdB and tcdC variants. Hypervirulent ST-11 (078) was the only member of clade 5, which was divergent from the other four clades within the MLST loci. However, it was closely related to the other clades within the tcdB and tcdC loci. ST-11 (078) may represent a divergent formerly non-toxigenic strain that acquired the PaLoc (at least) by genetic recombination. This study focused on human clinical isolates collected from a single geographic location, to achieve a uniquely high density of sampling. It sets a baseline of MLST data for future comparative studies investigating genotype virulence potential (using clinical severity data for these isolates), possible reservoirs of human CDI, and the evolutionary origins of hypervirulent strains.
format article
author Kate E Dingle
David Griffiths
Xavier Didelot
Jessica Evans
Alison Vaughan
Melina Kachrimanidou
Nicole Stoesser
Keith A Jolley
Tanya Golubchik
Rosalind M Harding
Tim E Peto
Warren Fawley
A Sarah Walker
Mark Wilcox
Derrick W Crook
author_facet Kate E Dingle
David Griffiths
Xavier Didelot
Jessica Evans
Alison Vaughan
Melina Kachrimanidou
Nicole Stoesser
Keith A Jolley
Tanya Golubchik
Rosalind M Harding
Tim E Peto
Warren Fawley
A Sarah Walker
Mark Wilcox
Derrick W Crook
author_sort Kate E Dingle
title Clinical Clostridium difficile: clonality and pathogenicity locus diversity.
title_short Clinical Clostridium difficile: clonality and pathogenicity locus diversity.
title_full Clinical Clostridium difficile: clonality and pathogenicity locus diversity.
title_fullStr Clinical Clostridium difficile: clonality and pathogenicity locus diversity.
title_full_unstemmed Clinical Clostridium difficile: clonality and pathogenicity locus diversity.
title_sort clinical clostridium difficile: clonality and pathogenicity locus diversity.
publisher Public Library of Science (PLoS)
publishDate 2011
url https://doaj.org/article/92cb5d60d0a1471a9ee089980e7b83ff
work_keys_str_mv AT kateedingle clinicalclostridiumdifficileclonalityandpathogenicitylocusdiversity
AT davidgriffiths clinicalclostridiumdifficileclonalityandpathogenicitylocusdiversity
AT xavierdidelot clinicalclostridiumdifficileclonalityandpathogenicitylocusdiversity
AT jessicaevans clinicalclostridiumdifficileclonalityandpathogenicitylocusdiversity
AT alisonvaughan clinicalclostridiumdifficileclonalityandpathogenicitylocusdiversity
AT melinakachrimanidou clinicalclostridiumdifficileclonalityandpathogenicitylocusdiversity
AT nicolestoesser clinicalclostridiumdifficileclonalityandpathogenicitylocusdiversity
AT keithajolley clinicalclostridiumdifficileclonalityandpathogenicitylocusdiversity
AT tanyagolubchik clinicalclostridiumdifficileclonalityandpathogenicitylocusdiversity
AT rosalindmharding clinicalclostridiumdifficileclonalityandpathogenicitylocusdiversity
AT timepeto clinicalclostridiumdifficileclonalityandpathogenicitylocusdiversity
AT warrenfawley clinicalclostridiumdifficileclonalityandpathogenicitylocusdiversity
AT asarahwalker clinicalclostridiumdifficileclonalityandpathogenicitylocusdiversity
AT markwilcox clinicalclostridiumdifficileclonalityandpathogenicitylocusdiversity
AT derrickwcrook clinicalclostridiumdifficileclonalityandpathogenicitylocusdiversity
_version_ 1718424241843470336